BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 20012975)

  • 1. [Pathogenesis and diagnosis of Sjögren's syndrome].
    Witte T
    Z Rheumatol; 2010 Feb; 69(1):50-6. PubMed ID: 20012975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.
    Reale M; D'Angelo C; Costantini E; Laus M; Moretti A; Croce A
    J Immunol Res; 2018; 2018():7510174. PubMed ID: 29977932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
    Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
    J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
    Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
    J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic markers of Sjögren's syndrome.
    Witte T
    Dev Ophthalmol; 2010; 45():123-128. PubMed ID: 20502032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
    Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
    J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
    Whittingham S; Mackay IR; Tait BD
    Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
    Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sjögren's syndrome].
    Witte T
    Z Rheumatol; 2014 Feb; 73(1):49-61. PubMed ID: 24554256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
    Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
    PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients.
    Verbaan H; Carlson J; Eriksson S; Larsson A; Liedholm R; Manthorpe R; Tabery H; Widell A; Lindgren S
    J Intern Med; 1999 Feb; 245(2):127-32. PubMed ID: 10081515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjogren's syndrome and keratoconjunctivitis sicca.
    Farris RL; Stuchell RN; Nisengard R
    Cornea; 1991 May; 10(3):207-9. PubMed ID: 2055025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren's syndrome: an update and overview.
    Kassan SS; Gardy M
    Am J Med; 1978 Jun; 64(6):1037-46. PubMed ID: 655189
    [No Abstract]   [Full Text] [Related]  

  • 17. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.
    Generali E; Costanzo A; Mainetti C; Selmi C
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):357-370. PubMed ID: 28871434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome.
    Pease CT; Charles PJ; Shattles W; Markwick J; Maini RN
    Br J Rheumatol; 1993 Jul; 32(7):574-7. PubMed ID: 8339127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.